Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MYM Nutraceuticals Inc MYMMF

MYM Nutraceuticals Inc is a Canada based company engaged in the business of acquiring and developing natural remedies. The company is focused on the medical marijuana business by producing cannabis growing facilities and products.


GREY:MYMMF - Post by User

Post by AndyMan2on Nov 22, 2019 6:16pm
231 Views
Post# 30384241

License November 29th 2019

License November 29th 2019Two weeks in a row Quebec gets two licenses issued.
License will be next Friday November 29th 2019.
This will be exactly one year since Sublime Culture completes migration to Healty Canada. Let's cross our fingers I am right. 


MYM’s Subsidiary, Sublime Culture Inc., Completes Migration to Health Canada’s Cannabis Tracking and Licensing System

Vancouver, B.C., November 29, 2018 – MYM Nutraceuticals Inc., (CSE: MYM) (“MYM”) is pleased to announce that its subsidiary, Sublime Culture Inc., has completed its migration to Health Canada’s Cannabis Tracking and Licensing System, or CTLS. The CTLS is a public facing web application that enables the submission of new license applications, request for amendments and license renewals in addition to submission of monthly tracking reports.

The oversight of the cannabis supply chain is a shared responsibility across many federal, provincial and territorial departments, industry and other stakeholders. One of Health Canada’s responsibilities is to track the flow of cannabis as a means of preventing the illegal inversion and diversion of cannabis into and out of the regulated system. Under this tracking system, a holder of a license for cultivation, a license for processing, or a license for sale for medical purposes is required to submit monthly reports to Health Canada.

Another of Health Canada’s responsibilities is to monitor patient access to cannabis for medical purposes. Again, where applicable, a holder of a license for sale for medical purposes is required to submit relevant information to Health Canada on a monthly basis.

“We are pleased that our subsidiary, Sublime Culture, has completed the migration to Health Canada’s new CTLS platform,” said Rob Gietl, CEO of MYM. “Now that Sublime Culture is compliant with the new guidelines, we are eager to receive our license for the Laval, Quebec facility and to begin production.

<< Previous
Bullboard Posts
Next >>